Amphastar Pharmaceuticals Q2 2016 Earnings

Amphastar reported second quarter 2016 results with total revenue of $120.8 million, representing 35% year-over-year growth, and contract revenue of $116.4 million. The company provided full-year 2016 guidance and discussed synergies from the Euticals acquisition and operational performance metrics.